Latest AngioDynamics Inc. Stories
AngioDynamics Inc. (NASDAQ:ANGO) today announced it will launch a new varicose vein therapy brand, VenaCure EVLT, at the American College of Phlebology (ACP) 22nd Annual Congress, November 6th to 9th at the Marco Island Marriott Resort & Spa in Florida.
Delcath Systems, Inc. (NASDAQ: DCTH) today announced the appointment of Mr. Eamonn Hobbs to Delcath's Board of Directors. Mr. Hobbs is President and Chief Executive Officer of AngioDynamics, Inc.
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, today reported financial results for the first quarter ended August 31, 2008.
AngioDynamics (NASDAQ:ANGO) announced today results from its RAPTURE study, which was conducted to identify the feasibility, efficacy and safety of percutaneous radiofrequency ablation (RFA) of malignant lung tumors.
- totally perplexed and mixed up.